Synthetic antibody phage libraries
    8.
    发明授权
    Synthetic antibody phage libraries 有权
    合成抗体噬菌体文库

    公开(公告)号:US07985840B2

    公开(公告)日:2011-07-26

    申请号:US10939309

    申请日:2004-09-09

    IPC分类号: C07K16/00 G01N33/53

    摘要: The invention provides comprising variant amino acids in CDRs of antibody variable domains. These polypeptides provide a source of great sequence diversity that can be used as a source for identifying novel antigen binding polypeptides. The invention also provides these polypeptides as fusion polypeptides to heterologous polypeptides such as at least a portion of phage or viral coat proteins, tags, and linkers. Libraries comprising a plurality of these polypeptides are also provided. In addition, methods of and compositions for generating and using these polypeptides and libraries are provided.

    摘要翻译: 本发明提供包含抗体可变结构域的CDR中的变体氨基酸。 这些多肽提供了可用作识别新型抗原结合多肽的来源的伟大序列多样性的来源。 本发明还提供这些多肽作为异源多肽的融合多肽,例如噬菌体或病毒外壳蛋白,标签和接头的至少一部分。 还提供了包含多个这些多肽的文库。 此外,提供了用于产生和使用这些多肽和文库的方法和组合物。

    Dr5 Antibodies and Uses Thereof
    10.
    发明申请
    Dr5 Antibodies and Uses Thereof 审中-公开
    Dr5抗体及其用途

    公开(公告)号:US20080248037A1

    公开(公告)日:2008-10-09

    申请号:US11547457

    申请日:2005-04-04

    摘要: The application provides antibodies which specifically bind to DR5 receptor. The anti-DR5 antibodies optionally contain CDR sequences identified using phage-display techniques. The DR5 antibodies can be used, for example, in methods where a modulation of the biological activities of Apo-2L and/or Apo-2L receptors is desired, including cancer and immune-related conditions.

    摘要翻译: 该应用提供特异性结合DR5受体的抗体。 抗DR5抗体任选地含有使用噬菌体展示技术鉴定的CDR序列。 DR5抗体可用于例如需要调节Apo-2L和/或Apo-2L受体的生物学活性的方法,包括癌症和免疫相关病症。